๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 9 Shanghai 8 Beijing 4 Chengdu 4 Huizhou 3
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou9 Shanghai8 Beijing4 Chengdu4 Huizhou3
All 31 locations
Target enrolment
to

Trials with a site in Shanghai

8 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Camrelizumab With Famitinib for Patients With Rare Head and Neck Malignancies
NCT07662681Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 1/2
40
Shanghai
2026-07-01
Recruiting
Efficacy and Safety of Paclitaxel Polymeric Micelles in Patients With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT07662746Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
29
Shanghai
2026-07-01
Recruiting
Becotatug Vedotin Combined With Pucotenlimab for Locally Recurrent Resectable Head and Neck Squamous Cell Carcinoma
NCT07632339Head and Neck Cancer
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
102
Shanghai
2026-06-16
Recruiting
Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC
NCT06876844Head and Neck Cancer, Head and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
24
Shanghai
2024-12-30
Recruiting
Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma
NCT06781567Adenoid Cystic Carcinoma, Head and Neck Cancer
HitGen Inc.
Phase 2
140
Shanghai
2024-12-13
Recruiting
U87 CAR-T in Patients With Advanced Head and Neck Tumors
NCT06614686Nasopharynx Cancer, Head and Neck Cancer
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Phase 1
20
Shanghai
2024-09-20
Recruiting
Induction IBI110 and Sintilimab with Chemotherapy in LA HNSCC
NCT06494943Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Fudan University
Phase 1/2
27
Shanghai
2024-06-26
Active, closed
Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia
NCT01266044Head And Neck Cancer
M.D. Anderson Cancer Center
Phase 3
435
Shanghai
2011-12-09
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Shanghai that also match the filters currently applied.

How many clinical trials are recruiting in Shanghai?

7 of the 8 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 0 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shanghai), 8 studies
PhaseStudiesRecruitingShare
Phase 24450%
Phase 1/22225%
Phase 11112.5%
Phase 31012.5%

Most active sponsors

Lead sponsors with the most studies (Shanghai)
Lead sponsorStudiesRecruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University44
Fudan University11
HitGen Inc.11
M.D. Anderson Cancer Center10
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.